Carregant...
GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment
The GlycA test is a recently developed proton nuclear magnetic resonance ((1)H-NMR) spectroscopy-based assay that has been gaining increased interest as a serum biomarker for systemic inflammation, and consequently, as a potential biomarker for cardiovascular disease (CVD) risk assessment. The test...
Guardat en:
| Publicat a: | J Lab Precis Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194207/ https://ncbi.nlm.nih.gov/pubmed/32363327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jlpm.2020.03.03 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|